Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics
Graphical Abstract
Positively charged HPMA copolymer (P-DEMA20) was internalized faster and more efficiently than negatively charged copolymer (P-MAA20) by LNCaP C4-2 cells.
Introduction
Employment of macromolecular drug carriers for the delivery of anticancer therapeutics has resulted in significant improvements in treatment efficacy [1]. A variety of macromolecular drug carriers are currently under investigation. An ideal macromolecular drug carrier should possess preferable pharmacokinetics, highly efficient cellular uptake and preferential subcelluar trafficking. These biological merits are determined to a large extent by physicochemical characteristics of the macromolecular drug carriers. For instance, molecular weight has an impact on the intravascular half-life and renal clearance [2]. Positively charged macromolecular drug carriers are internalized by cells more efficiently than negatively charged carriers, however their uptake occurs in the majority of cells [3]. Nevertheless, how the physicochemical characteristics of drug carriers determine their uptake and subcellular trafficking remains largely unknown.
Understanding the uptake and subcellular trafficking of macromolecular drug carriers by cells relies on knowledge of the complexity and diversity of endocytic pathways. Many endocytic pathways have been identified and a variety of classification schemes have been proposed. Based on the cargo, endocytosis is classified as phagocytosis or pinocytosis (fluid-phase endocytosis) [4]. Based on receptors, endocytosis can be designated as receptor mediated endocytosis specified by involvement of specific high-affinity receptors, adsorptive endocytosis denoted by nonspecific binding of solutes to the cell membrane, and regular endocytosis taking up surrounding fluid unspecifically [5]. Most common classification schemes of endocytosis are based on protein machinery that facilitates the process, such as clathrin-mediated endocytosis, and clathrin independent endocytosis [5], [6], [7], [8]. Clathrin independent endocytosis is further categorized as caveolae-mediated endocytosis and clathrin- and caveolin-independent endocytosis [5], [7] or dynamin-dependent and dynamin-dependent endocytosis [7], [8]. Dynamin is a GTPase protein that surrounds the neck of vesicle pits and facilitates the scission of many, but not all vesicles, such as clathrin-coated, caveolae-mediated and clathrin- and caveolin-independent vesicles [9]. Macropinocytosis is a distinct pathway of pinocytosis [5], [10], [11]; traditionally, macropinocytosis was designated as bulk non-selective and constitutive uptake of extracellular fluid through plasma membrane protrusion or ruffling. It has been recently recognized as an elaborately coordinated process including actin-mediated membrane reorganization and regulation of signaling, such as phosphoinositide (PI) 3-kinases [10], [11].
Hydrophilic and neutral copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) have been broadly used as linear water soluble polymeric drug carriers for therapeutic applications [12], [13]. Several drug-polymer conjugates based on HPMA copolymers have been studied clinically. A doxorubicin–HPMA copolymer conjugate PK1 was the first HPMA copolymer drug conjugate to enter clinical trials [14]. Phase II trial of PK1 in breast, non-small cell lung and colorectal cancers suggested that polymer-bound therapeutics are capable of improving anticancer activities [15]. PK2 [16], a compound related to PK1, and several HPMA copolymer drug conjugates containing taxol, camptothecin, and platinum entered Phase I clinical trials [17], [18], [19], [20]. HPMA copolymers are internalized into cells through endocytosis as shown in an early study on HPMA copolymers containing different degradable peptidyl side chains using rat visceral yolk sacs cultured in vitro [21]. Incorporation of hydrophobic tyrosinamide residues, bound either directly to the polymer main chain or through a glycylglycine linker, enhanced the uptake of HPMA copolymers [22]. More recently, endocytic uptake and subcellular trafficking of a HPMA antibody conjugate have been studied [23].
In the present study, the relationship between the mechanisms of endocytic uptake and subcellular trafficking of a large array of fluorescently-labeled, HPMA based copolymers and their physicochemical characteristics, such as charge, molecular weight and hydrophobicity, was studied. The array was composed of 9 HPMA copolymers with 5 comonomers possessing functional groups with positive or negative charges or containing a short hydrophobic peptide. FITC-labeled polyHPMA (P-FITC) was used as control. These copolymers were fractionated using size exclusion chromatography to create parallel Mw “ladders” consisting of 10 narrowly polydisperse fractions with molecular weights ranging from 10 to 200 kDa. Cellular uptake of the HPMA copolymer fractions and involvement of different endocytic pathways were assessed by flow cytometry in cultured prostate cancer cells. Subcellular trafficking of membrane vesicles carrying copolymers was characterized by living cell confocal microscopy.
Section snippets
Materials
All chemicals and solvents used were of reagent grade or better unless otherwise stated. The monomers, MAA (methacrylic acid), SEMA (2-sulfoethyl methacrylate), DEMA (2-(N,N-dimethylamino)ethyl methacrylate), and MATC (methacryloyloxyethyl trimethylammonium chloride) were purchased from PolySciences (Warrington, PA), Alexa Fluor 647-labeled dextran 10 kDa and Hoechst 33342 were purchased from Molecular Probes (Carlsbad, CA). Chlorpromazine, filipin complex, mevinolin, Dynasore, 5-(N-ethyl-N
Design and characterization of HPMA copolymers containing different functional groups
A large array of HPMA copolymers with widely disparate functional groups was generated to provide HPMA copolymers with a variety of physicochemical characteristics [24]. For hydrophilic copolymers, four different charged comonomers in two contents were employed to bestow different charge and density on the copolymers: MATC — a strong base, DEMA — a weak base, MAA — a weak acid, and SEMA — a strong acid (Scheme 1). A peptide-containing monomer, N-methacryloylglycylphenylalanylleucylglycine
Discussion
Understanding the interdependent roles that fundamental physicochemical characteristics of drug carriers play on the cellular uptake and intracellular trafficking is extremely important. For instance, one can design polymeric drug carriers with physicochemical characteristics that enable polymer–drug conjugates to be taken up efficiently or to enrich the proper membrane confined organelles, such as endosomes or lysosomes. Therefore, suitable endosomal escape or lysosomal enzymatic cleavage can
Conclusions
Endocytic uptake of HPMA copolymers is determined by their physicochemical characteristics, such as charge and molecular weight. Positively charged copolymers were internalized into cells through adsorptive endocytosis whereas negatively charged copolymers through fluid phase endocytosis. Fast uptake was observed for positively charged copolymers whereas slow and minimal uptake for negatively charged copolymers. The uptake of copolymers was in a molecular weight dependent manner. In negatively
Acknowledgment
The research was supported in part by NIH grant CA132831 from the National Cancer Institute. C4-2 prostate cancer cells were kindly provided by Dr. Ursula Elsässer-Beile, University of Freiburg, Germany. We thank Michael Jacobsen for carefully editing the manuscript.
References (52)
- et al.
Biodistribution and antitumor efficacy of long circulating N-(2-hydroxypropyl)methacrylamide copolymer–doxorubicin conjugates in nude mice
Eur. J. Cancer
(2001) - et al.
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Eur. J. Pharm. Biopharm.
(2000) - et al.
Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system
Biochim. Biophys. Acta
(1981) - et al.
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers
Biochim. Biophys. Acta
(1984) - et al.
Low-affinity transport of FITC-albumin in alveolar type II epithelial cell line RLE-6TN
Drug Metab. Pharmacokinet.
(2008) - et al.
Dynasore, a cell-permeable inhibitor of dynamin
Dev. Cell
(2006) - et al.
Rab conversion as a mechanism of progression from early to late endosomes
Cell
(2005) - et al.
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
J. Biol. Chem.
(1987) - et al.
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Biochem. Biophys. Res. Commun.
(2007) - et al.
The effect of surface functionality on cellular trafficking of dendrimers
Biomaterials
(2008)
The emergence of clathrin-independent pinocytic pathways
Curr. Opin. Cell Biol.
Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99
Anal. Biochem.
The use of fluorescence microscopy to define polymer localization to the late endocytic compartments in cells that are targets for drug delivery
J. Control. Release
Polymer therapeutics: concepts and applications
Angew. Chem. Int. Ed.
Interaction of a cationic N-(2-hydroxypropyl)methacrylamide copolymer with rat visceral yolk sac cultured in vitro and rat liver in vivo
J. Bioact. Compat. Polym.
Endocytosis
Physiol. Rev.
Regulated portals of entry into the cell
Nature
Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers
Biochim. Biophys. Acta
Pathways of clathrin-independent endocytosis
Nat. Rev. Mol. Cell Biol.
Clathrin-independent internalization and recycling
J. Cell Mol. Med.
The dynamin superfamily: universal membrane tubulation and fission molecules?
Nat. Rev. Mol. Cell Biol.
Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides
J. Cell Mol. Med.
Defining macropinocytosis
Traffic
Soluble biomedical polymers
Polim. Med.
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates, Cancer Res. Campaign Phase I/II Committee
Clin. Cancer Res.
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Int. J. Oncol.
Cited by (54)
Nanotherapeutics for prostate cancer treatment: A comprehensive review
2024, BiomaterialsDye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake
2023, Nanomedicine: Nanotechnology, Biology, and MedicineHPMA-based polymeric conjugates in anticancer therapeutics
2020, Drug Discovery TodayEnhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform
2020, International Journal of PharmaceuticsCitation Excerpt :Therefore, the superior cellular uptake of PHNGFLG over H1-NrTP6 may be due to that more involved endocytosis pathways. Similar results were observed by other groups that the involvement of multiple endocytisis pathways showed better internalization (Liu et al., 2010; Sahay et al., 2008; Seib et al., 2007). The influence of NrTP6 peptidic ligands on nucleus targeting in three tumor cell lines have investigated by flow cytometry.
Polymer nanomedicines
2020, Advanced Drug Delivery ReviewsCitation Excerpt :Nanomedicines can surmount the efflux pump-type of multidrug resistance [295]. They are internalized in the cells by endocytosis [198] in contrast to diffusion of free low molecular weight drugs. Internalization in membrane limited organelles avoids interaction with P-glycoprotein (Pgp), an ATP-dependent efflux pump that constricts the transport of drugs into the cytoplasm [296].